Dermira (NASDAQ: DERM) reported Q3 EPS of ($0.09), $0.06 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $17.6 million versus the consensus estimate of $18.66 million.

For earnings history and earnings-related data on Dermira (DERM) click here.